Pivot secures $32M in Series C

Sunnyvale, CA-based Pivot Medical has raised $32 million in a Series C round led by new investor Adams Street Partners. Delphi Ventures also participated, as well as founding investor Montreux Equity Partners and existing investor Ivy Capital Partners.

The company will use the funds for the commercial rollout of its Pivot hip arthroscopy system in the U.S. and Europe and to expand its clinical research programs. The system was designed make hip arthroscopy safer, more efficient and easier for physicians to perform, according to a company statement.

"Pivot Medical was founded to deliver new technologies that dramatically advance the field of minimally invasive hip restoration, and we are meeting this commitment with a comprehensive line of innovative, highly differentiated products that will enable physicians to successfully treat their hip pain patients while preserving the delicate and complex hip anatomy," said Jack Giroux, president and CEO of Pivot.

- get more from the Pivot Medical release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.